MetaCap

Blue Water Acquisition III Unit. (BLUWU) vs Scinai Immunotherapeutics (SCNI)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Relative performance

BLUWU-0.76%SCNI-54.96%
+3%-27%-58%
Oct 7, 20261 yearNov 11, 2026
BLUWU-0.76%SCNI-66.10%
+3%-33%-69%
Oct 5, 20265 yearsNov 9, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

BLUWU versus SCNI key metrics
MetricBLUWUSCNI
Share price$10.42$1.58
Market cap—$1.04M
1-day change0.00%+1.66%
YTD return-1.23%—
P/E ratio (TTM)—0.12
EPS (TTM)—$13.18
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$1.31M
Revenue growth (YoY)—+99.24%
Net income (latest FY)$4.67M$-8.31M
Gross margin—-202.29%
Operating margin—-575.29%
Net margin—-633.64%
52-week high$12.85$52.00
52-week low$0.00$1.13
Distance from 52-week high-18.91%-96.96%
Average volume45576.34K
Shares outstanding—657.61K
Employees—45
SectorHealth CareHealth Care
IndustryBiotechnology: Biological Products (No Diagnostic Substances)Biotechnology: Biological Products (No Diagnostic Substances)

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Blue Water Acquisition III Unit.

BLUWU stock →

Blue Water Acquisition Corp. III does not have significant operations.

Health Care · Biotechnology: Biological Products (No Diagnostic Substances)

About Scinai Immunotherapeutics

SCNI stock →

Scinai Immunotherapeutics Ltd., together with its subsidiaries, operates as a biopharmaceutical company in Israel and internationally. It engages in the research and development of IL-17 NanoAb, a VHH-based antibody platform for the treatment of immune-mediated and inflammatory diseases, including psoriasis; and PC111, a human monoclonal antibody for the treatment of pemphigus, Steven Johnson's syndrome, and toxic epidermal necrolysis.

Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 45 employees

BLUWU vs SCNI FAQ

Are Blue Water Acquisition III Unit. and Scinai Immunotherapeutics in the same industry?

Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.

More comparisons